These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 674871)

  • 21. Determinants of response to immunosuppressive therapy in idiopathic pulmonary fibrosis.
    van Oortegem K; Wallaert B; Marquette CH; Ramon P; Perez T; Lafitte JJ; Tonnel AB
    Eur Respir J; 1994 Nov; 7(11):1950-7. PubMed ID: 7875264
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combination chemotherapy in disseminated carcinoma of the breast.
    Kaufman S; Goldstein M
    Surg Gynecol Obstet; 1973 Jul; 137(1):83-6. PubMed ID: 4714324
    [No Abstract]   [Full Text] [Related]  

  • 23. Randomized comparison of cladribine alone or in combination with cyclophosphamide, and cyclophosphamide, vincristine and prednisone in previously untreated low-grade B-cell non-Hodgkin lymphoma patients: final report of the Polish Lymphoma Research Group.
    Kalinka-Warzocha E; Wajs J; Lech-Maranda E; Ceglarek B; Holowiecki J; Federowicz I; Walewski J; Czyz J; Robak T; Warzocha K;
    Cancer; 2008 Jul; 113(2):367-75. PubMed ID: 18470902
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An evaluation of five drug combination chemotherapy in the management of recurrent carcinoma of the breast.
    Lee JM; Abeloff MD; Lenhard RE; Baker RR
    Surg Gynecol Obstet; 1974 Jan; 138(1):77-80. PubMed ID: 4809006
    [No Abstract]   [Full Text] [Related]  

  • 25. [Treatment of idiopathic pulmonary fibrosis].
    Dury S
    Rev Mal Respir; 2006 Apr; 23(2 Pt 2):5S87-5S91. PubMed ID: 16788517
    [No Abstract]   [Full Text] [Related]  

  • 26. [Combined treatment with factor VIII and immunosuppressive agents in a young woman with acquired factor VIII inhibitor].
    José Aguado M; Carrasco V; Periago A; Bello T; González E; García-Talavera J
    Sangre (Barc); 1996 Apr; 41(2):147-50. PubMed ID: 9045356
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic management of idiopathic pulmonary fibrosis: an evidence-based approach.
    Nathan SD
    Clin Chest Med; 2006 Mar; 27(1 Suppl 1):S27-35, vi. PubMed ID: 16545630
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of Mega-COMLA (cyclophosphamide, cytarabine, vincristine, and methotrexate followed by leucovorin and prednisone) plus CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) in the treatment of lymphoid neoplasms with very poor prognosis.
    Hainsworth JD; Wolff SN; Stein RS; Greer JP; Cousar JB; Greco FA
    Cancer Treat Rep; 1986 Aug; 70(8):953-8. PubMed ID: 3015406
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term follow-up of patients with intermediate or high-grade non-Hodgkin lymphoma treated with a combination of cyclophosphamide, epirubicin, vincristine, and prednisone.
    Rossini F; Terruzzi E; Perego D; Miccolis I; Rivolta F; Manca E; Pogliani EM
    Cancer; 2004 Jan; 100(2):350-5. PubMed ID: 14716771
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-Hodgkin's lymphomas-present status of chemotherapy.
    Young CW
    Clin Bull; 1975; 5(1):20-3. PubMed ID: 776444
    [No Abstract]   [Full Text] [Related]  

  • 31. Lymphoma in cats treated with a weekly cyclophosphamide-, vincristine-, and prednisone-based protocol: 114 cases (1998-2008).
    Waite AH; Jackson K; Gregor TP; Krick EL
    J Am Vet Med Assoc; 2013 Apr; 242(8):1104-9. PubMed ID: 23547674
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High grade nonHodgkin's lymphoma: management with moderate dose combination chemotherapy.
    Palmer MC; Fitzharris BM; Robinson BA; Atkinson CH; Colls BM
    N Z Med J; 1988 May; 101(846):255-8. PubMed ID: 3374896
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Combination chemotherapy in advanced carcinoma of the breast].
    Carmo-Pereira J; Galvão-Teles A; Oliveira Costa F; Bak Gordon R; Henriques E; Dória JM; Freire Cruz M; Silveira Botelho L
    Arq Patol; 1974; 46(2-3):309-23. PubMed ID: 4458643
    [No Abstract]   [Full Text] [Related]  

  • 34. [Results of combined chemotherapy of lymphosarcoma with cyclophosphamide, vincristine and prednisolone].
    Abdyldaev RA; Kruglova GV
    Vopr Onkol; 1983; 29(4):83-5. PubMed ID: 6687966
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disseminated breast carcinoma. Treatment with combination chemotherapy.
    Spigel SC; Coltman CA; Costanzi JJ
    Arch Intern Med; 1973 Oct; 132(4):575-7. PubMed ID: 4742410
    [No Abstract]   [Full Text] [Related]  

  • 36. Combined therapy in the treatment of primary mediastinal B-cell lymphoma: conventional versus escalated chemotherapy.
    Avilés A; García EL; Fernández R; Gonzalez JL; Neri N; Díaz-Maqueo JC
    Ann Hematol; 2002 Jul; 81(7):368-73. PubMed ID: 12185505
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase I/II trial of nonpegylated liposomal doxorubicin, cyclophosphamide, vincristine, and prednisone in the treatment of newly diagnosed aggressive non-Hodgkin's lymphoma.
    Tulpule A; Espina BM; Berman N; Buchanan LH; Smith DL; Sherrod A; Dharmapala D; Gee C; Boswell WD; Nathwani BN; Welles L; Levine AM
    Clin Lymphoma Myeloma; 2006 Jul; 7(1):59-64. PubMed ID: 16879771
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A high tumor-associated macrophage content predicts favorable outcome in follicular lymphoma patients treated with rituximab and cyclophosphamide-doxorubicin-vincristine-prednisone.
    Taskinen M; Karjalainen-Lindsberg ML; Nyman H; Eerola LM; Leppä S
    Clin Cancer Res; 2007 Oct; 13(19):5784-9. PubMed ID: 17908969
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year results of a Southwest Oncology Group study.
    Rivkin SE; Green SJ; Lew D; Costanzi JJ; Athens JW; Osborne CK; Vaughn CB; Martino S
    Cancer; 2003 Jan; 97(1):21-9. PubMed ID: 12491501
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combination of ofatumumab and reduced-dose CHOP for diffuse large B-cell lymphomas in patients aged 80 years or older: an open-label, multicentre, single-arm, phase 2 trial from the LYSA group.
    Peyrade F; Bologna S; Delwail V; Emile JF; Pascal L; Fermé C; Schiano JM; Coiffier B; Corront B; Farhat H; Fruchart C; Ghesquieres H; Macro M; Tilly H; Choufi B; Delarue R; Fitoussi O; Gabarre J; Haioun C; Jardin F
    Lancet Haematol; 2017 Jan; 4(1):e46-e55. PubMed ID: 28041583
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.